Skip to main content

Table 3 Angiographic and procedural characteristics of the study population

From: Combined value of left ventricular ejection fraction and the Model for End-Stage Liver Disease (MELD) score for predicting mortality in patients with acute coronary syndrome who were undergoing percutaneous coronary intervention

Variable Survivors (n = 663) Non-sruvivors (n = 183) P-value
Vessel involvement    0.374
 LMCA 0(0) 1 (0.6)  
 LAD 304 (46) 76 (42)  
 CX 99 (15) 23 (13)  
 RCA 209 (32) 65 (36)  
 Others 51 (8) 19 (10)  
Multi-vessel disease n (%) 296 (45) 110 (60) < 0.001
Stent use n (%) 634 (96) 173 (95) 0.533
Stent length. mm 21 (18–28) 23 (18–28) 0.722
Stent diameter, mm 3.4 ± 0.6 3.5 ± 0.6 0.887
Stent type    0.141
 DES n (%) 67 (10) 10 (6)  
 BMS n (%) 583 (90) 168 (94)  
Tirofiban use n (%) 257 (39) 66 (36) 0.506
  1. LMCA left main coronary artery, LAD left anterior descending coronary artery, CX circumflex coronary artery, RCA right coronary artery, DES drug-eluting stent, BMS bare-metal stent